And why he says the stock could see double-digit upside over the next 12 months.
Read MorePlus, the World Bank cut its outlook for global growth for this year, iPhone shipments to China surged 18% last month, and several retailers reported a disappointing holiday sales season.
Read MorePlus, initial jobless claims for last week were released, Democrats and Republicans are still in a standoff over the Trump impeachment trial, and Interpol issued an arrest warrant to Lebanon for ousted Nissan chair Ghosn.
Read MorePlus, Tesla began delivering Model 3s from its new Shanghai factory, and AstraZeneca and Merck’s cancer drug just got approved to treat pancreatic cancer.
Read MoreBuy Target – $14.50 or better Sell Target – TradersPro Sell Signal Aravive, Inc., a clinical stage biotechnology company, focuses on developing therapies for solid tumors and hematologic malignancies. Its lead candidate is AVB-S6-500, a soluble Fc-fusion protein, which is in Phase 1b/2 clinical trials for the treatment of platinum- resistant recurrent ovarian cancer, as […]
Read MorePlus, the stocks that led the market this decade and the ones analysts are bullish on for the year ahead.
Read MoreNetflix may have won the 2010s, but these 5 stocks could be big winners in the new decade.
Read MoreBuy Target – $28.50 or better Sell Target – TradersPro Sell Signal XOMA Corporation, a biotech company, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary […]
Read MorePlus, the House Judiciary Committee may put forward new articles of impeachment against President Trump pending a key testimony, and Tesla shares finally hit $420.
Read MorePlus, China is lowing tariffs on more than 850 products from the U.S., Sarepta Therapeutics got a massive investment from Roche, and DraftKings is going public.
Read MoreGoldman Sachs says all three Strong Buy stocks could see double-digit upside next year.
Read MorePlus, Trump was impeached by the House, existing home sales slumped in November, and Micron forecast for its financial recovery in 2020.
Read MoreBuy Target $2.30 or better Sell Target – TradersPro Sell Signal Fortress Biotech, Inc. develops and commercializes pharmaceutical and biotechnology products. It markets dermatology products, such as Targadox for acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; Ala-Scalp and Triderm, which are used […]
Read MorePlus, tech stocks are soaring, questions remain on the U.S.-China phase one trade agreement, and homebuilder confidence surged to its highest level in 20 years this month.
Read MoreBuy Target $13.97 or better Sell Target – TradersPro Sell Signal Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and […]
Read More